S100A8 and S100A9 in inflammation and cancer.

[1]  P. Szlosarek,et al.  Tumour necrosis factor-α as a tumour promoter , 2006 .

[2]  Y. Ben-Neriah,et al.  NF-κB inhibition: A double-edged sword in cancer? , 2006 .

[3]  K. H. Richter,et al.  A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin. , 2006, The American journal of pathology.

[4]  David J Weber,et al.  S100A4, a Mediator of Metastasis* , 2006, Journal of Biological Chemistry.

[5]  F. Kokocinski,et al.  Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development , 2006, Oncogene.

[6]  T. Gant,et al.  Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin. , 2005, Carcinogenesis.

[7]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[8]  G. Christofori,et al.  Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment , 2006, Cellular and Molecular Life Sciences CMLS.

[9]  C. Enerbäck,et al.  Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development. , 2005, International journal of oncology.

[10]  T. Furuya,et al.  Genomic alterations detected by comparative genomic hybridization in primary lung adenocarcinomas with special reference to the relationship with DNA ploidy. , 2005, Oncology reports.

[11]  P. Watson,et al.  BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. , 2005, Cancer research.

[12]  Nozawa,et al.  S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma. , 2005, Pathology, research and practice.

[13]  J. DiGiovanni,et al.  Differential gene expression in epidermis of mice sensitive and resistant to phorbol ester skin tumor promotion , 2005, Molecular carcinogenesis.

[14]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[15]  E. Wagner,et al.  Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins , 2005, Nature.

[16]  I. Papassotiriou,et al.  Severe Anemia and Neutropenia Associated With Hyperzincemia and Hypercalprotectinemia , 2005, Journal of pediatric hematology/oncology.

[17]  D. Stern,et al.  Understanding RAGE, the receptor for advanced glycation end products , 2005, Journal of Molecular Medicine.

[18]  Diane M Simeone,et al.  S100P Promotes Pancreatic Cancer Growth, Survival, and Invasion , 2005, Clinical Cancer Research.

[19]  Rainer Grobholz,et al.  Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate Cancer , 2005, Clinical Cancer Research.

[20]  K. H. Richter,et al.  c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis. , 2005, The American journal of pathology.

[21]  D. Stern,et al.  Advanced Glycation End Product Receptor‐Mediated Cellular Dysfunction , 2005, Annals of the New York Academy of Sciences.

[22]  M. Blumenberg,et al.  Pathway-specific Profiling Identifies the NF-κB-dependent Tumor Necrosis Factor α-regulated Genes in Epidermal Keratinocytes* , 2005, Journal of Biological Chemistry.

[23]  J. Roth,et al.  Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14) , 2005, Biological chemistry.

[24]  N. Wong,et al.  Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma , 2005, Modern Pathology.

[25]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[26]  D. Foell,et al.  Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. , 2005, Blood.

[27]  S. Cross,et al.  Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers , 2005, Histopathology.

[28]  P. Schirmacher,et al.  Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade – results of an explorative CGH meta-analysis , 2005, British Journal of Cancer.

[29]  Marisa Martin-Fernandez,et al.  Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes , 2005, Oncogene.

[30]  H. Moses,et al.  Tumor-stroma interactions. , 2005, Current opinion in genetics & development.

[31]  J. Palefsky,et al.  Inhibition of Human Papillomavirus Type 16 E7 Phosphorylation by the S100 MRP-8/14 Protein Complex , 2005, Journal of Virology.

[32]  L. Coussens,et al.  Soluble mediators of inflammation during tumor development. , 2005, Advances in cancer research.

[33]  I. Thorey,et al.  MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. , 2004, Blood.

[34]  James L. Abbruzzese,et al.  Protein Expression Profiles in Pancreatic Adenocarcinoma Compared with Normal Pancreatic Tissue and Tissue Affected by Pancreatitis as Detected by Two-Dimensional Gel Electrophoresis and Mass Spectrometry , 2004, Cancer Research.

[35]  P. Angel,et al.  AP-1 subunits: quarrel and harmony among siblings , 2004, Journal of Cell Science.

[36]  D. Foell,et al.  Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis , 2004, The Journal of pathology.

[37]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[38]  C. Heizmann,et al.  S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). , 2004, Biochemical and biophysical research communications.

[39]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[40]  L. Murphy,et al.  S100 proteins and their influence on pro-survival pathways in cancer. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[41]  Kathleen C. Lee,et al.  S100 proteins in the epidermis. , 2004, The Journal of investigative dermatology.

[42]  L. Murphy,et al.  S100A7 and the progression of breast cancer , 2004, Breast Cancer Research.

[43]  D. Foell,et al.  Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[44]  R. Silber,et al.  RAGE: A New Pleiotropic Antagonistic Gene? , 2004, Annals of the New York Academy of Sciences.

[45]  E. Schleicher,et al.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. , 2004, The Journal of clinical investigation.

[46]  T. Teratani,et al.  S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. , 2004, European journal of cancer.

[47]  T. Woodruff,et al.  THE ROLE OF THE COMPLEMENT SYSTEM IN ISCHEMIA-REPERFUSION INJURY , 2004, Shock.

[48]  T. Mok,et al.  Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. , 2004, European journal of cancer.

[49]  W. Greene,et al.  Shaping the nuclear action of NF-κB , 2004, Nature Reviews Molecular Cell Biology.

[50]  Sakari Knuutila,et al.  Clustering of molecular alterations in gastroesophageal carcinomas. , 2004, Neoplasia.

[51]  Zhihua Liu,et al.  Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray , 2004, Oncogene.

[52]  A. Huvos,et al.  Frequent amplification and rearrangement of chromosomal bands 6p12‐p21 and 17p11.2 in osteosarcoma , 2004, Genes, chromosomes & cancer.

[53]  K. Preissner,et al.  The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins , 2003, The Journal of experimental medicine.

[54]  G. Glinsky,et al.  Common malignancy-associated regions of transcriptional activation (MARTA) in human prostate, breast, ovarian, and colon cancers are targets for DNA amplification. , 2003, Cancer letters.

[55]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[56]  C. Heizmann,et al.  Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. , 2003, Biochemical and biophysical research communications.

[57]  R. Flavell,et al.  JunD mediates survival signaling by the JNK signal transduction pathway. , 2003, Molecular cell.

[58]  P. Lichter,et al.  Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells , 2003, International journal of cancer.

[59]  A. Seth,et al.  Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. , 2003, Anticancer research.

[60]  G. Glinsky,et al.  Malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers. , 2003, Neoplasia.

[61]  R. Donato,et al.  Intracellular and extracellular roles of S100 proteins , 2003, Microscopy research and technique.

[62]  W. Nacken,et al.  S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity , 2003, Microscopy research and technique.

[63]  T. Vogl,et al.  Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. , 2003, Trends in immunology.

[64]  N. Hogg,et al.  Myeloid Cell Function in MRP-14 (S100A9) Null Mice , 2003, Molecular and Cellular Biology.

[65]  P. Rouleau,et al.  Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion 1 , 2003, The Journal of Immunology.

[66]  P. Watson,et al.  Psoriasin (S100A7) expression is altered during skin tumorigenesis , 2003, BMC dermatology.

[67]  W. Nacken,et al.  Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro , 2003, Molecular and Cellular Biology.

[68]  S. Ahn,et al.  Gain in 1q is a Common Abnormality in Phyllodes Tumours of the Breast , 2003, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[69]  N. Colburn,et al.  Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4 , 2003 .

[70]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[71]  A. Schmidt,et al.  Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. , 2002, Advanced drug delivery reviews.

[72]  W. Winkelmann,et al.  Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas , 2002, International journal of cancer.

[73]  C. Moskaluk,et al.  Gastric cancers overexpress S100A calcium-binding proteins. , 2002, Cancer research.

[74]  B. Wolska-Kuśnierz,et al.  Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism , 2002, The Lancet.

[75]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[76]  P. Vignais,et al.  The S100A8/A9 protein as a partner for the cytosolic factors of NADPH oxidase activation in neutrophils. , 2002, European journal of biochemistry.

[77]  A. Schmidt,et al.  RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease , 2002, Cellular and Molecular Life Sciences CMLS.

[78]  K. H. Richter,et al.  Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis , 2002, Oncogene.

[79]  C. Heizmann,et al.  S100 proteins: structure, functions and pathology. , 2002, Frontiers in bioscience : a journal and virtual library.

[80]  F. Balkwill.  Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.

[81]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[82]  A. Bode,et al.  Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. , 2002, Cancer research.

[83]  A. Schmidt,et al.  Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes , 2002, Ageing Research Reviews.

[84]  N. Hogg,et al.  The S100 Family Heterodimer, MRP-8/14, Binds with High Affinity to Heparin and Heparan Sulfate Glycosaminoglycans on Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[85]  S. Petersen,et al.  Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases , 2002, Virchows Archiv.

[86]  S. Petersen,et al.  Chromosomal imbalances of primary and metastatic lung adenocarcinomas , 2002, The Journal of pathology.

[87]  A. Schmidt,et al.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.

[88]  I. Thorey,et al.  The Ca2+-binding Proteins S100A8 and S100A9 Are Encoded by Novel Injury-regulated Genes* , 2001, The Journal of Biological Chemistry.

[89]  G. Christofori,et al.  Keratinocyte-specific onset of serine protease BSSP expression in experimental carcinogenesis. , 2001, The Journal of investigative dermatology.

[90]  Weiya Ma,et al.  Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. , 2001, Cancer research.

[91]  T. Teratani,et al.  Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation. , 2001, Oncology reports.

[92]  C. Muro-Cacho,et al.  Genetic and molecular abnormalities in tumors of the bone and soft tissues. , 2001, Cancer control : journal of the Moffitt Cancer Center.

[93]  A. Varki,et al.  Two Proteins Modulating Transendothelial Migration of Leukocytes Recognize Novel Carboxylated Glycans on Endothelial Cells1 , 2001, The Journal of Immunology.

[94]  M J Bissell,et al.  Tumors are unique organs defined by abnormal signaling and context. , 2001, Seminars in cancer biology.

[95]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[96]  A. Schmidt,et al.  Alzheimer's disease: inside, outside, upside down. , 2001, Biochemical Society Symposium.

[97]  W. Nacken,et al.  Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. , 2001, Biochemistry.

[98]  C. Sorg,et al.  Transendothelial migration of 27E10+ human monocytes. , 2000, International immunology.

[99]  K. Arai,et al.  Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma. , 2000, Medical oncology.

[100]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[101]  Carolyn L. Geczy,et al.  IFN-γ and TNF Regulate Macrophage Expression of the Chemotactic S100 Protein S100A81 , 2000, The Journal of Immunology.

[102]  N. Colburn,et al.  Activator protein 1 (AP-1)– and nuclear factor κB (NF-κB)–dependent transcriptional events in carcinogenesis , 2000 .

[103]  N. Wulffraat,et al.  Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[104]  J. Garin,et al.  Calcium‐dependent secretion in human neutrophils: A proteomic approach , 2000, Electrophoresis.

[105]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[106]  S. Petersen,et al.  Chromosomal alterations in the clonal evolution to the metastatic stage ofquamous cell carcinomas of the lung , 1999, British Journal of Cancer.

[107]  C. Kerkhoff,et al.  The Regulatory Role of MRP8 (S100A8) and MRP14 (S100A9) in the Transendothelial Migration of Human Leukocytes , 2000, Pathobiology.

[108]  C. Kerkhoff,et al.  The Two Calcium-binding Proteins, S100A8 and S100A9, Are Involved in the Metabolism of Arachidonic acid in Human Neutrophils* , 1999, The Journal of Biological Chemistry.

[109]  N. Colburn,et al.  Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[110]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[111]  L. Taichman,et al.  A partial catalog of proteins secreted by epidermal keratinocytes in culture. , 1999, The Journal of investigative dermatology.

[112]  C. Sorg,et al.  Identification of epithelial and myeloid‐specific DNA elements regulating MRP14 gene transcription , 1999, Journal of cellular biochemistry.

[113]  J. Knížek,et al.  The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: The S100A9 and S100A8 positive cells underlie and invade tumor mass , 1999, Electrophoresis.

[114]  W. Chazin,et al.  High Level Expression and Dimer Characterization of the S100 EF-hand Proteins, Migration Inhibitory Factor-related Proteins 8 and 14* , 1998, The Journal of Biological Chemistry.

[115]  W. Brück,et al.  Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosis , 1998, Neuroscience Letters.

[116]  S. Yuspa,et al.  The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. , 1998, Journal of dermatological science.

[117]  N. Hogg,et al.  The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. , 1998, Journal of immunology.

[118]  C. Geczy,et al.  Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli. , 1997, Blood.

[119]  A. Macela,et al.  Overexpression of calcium-binding protein calgranulin B in colonic mucosal diseases. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[120]  P. Schraml,et al.  Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma. , 1997, Cancer research.

[121]  M. Mcguire,et al.  Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. , 1997, Cancer genetics and cytogenetics.

[122]  M. Hartmann,et al.  Myeloid-related Protein (MRP) 8 and MRP14, Calcium-binding Proteins of the S100 Family, Are Secreted by Activated Monocytes via a Novel, Tubulin-dependent Pathway* , 1997, The Journal of Biological Chemistry.

[123]  B. Spiegelman,et al.  c-fos is required for malignant progression of skin tumors , 1995, Cell.

[124]  I. Stříž,et al.  Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis. , 1995, American journal of respiratory and critical care medicine.

[125]  K. Schmid,et al.  Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. , 1995, Digestion.

[126]  A. Kopp-Schneider,et al.  Malignant progression of papillomas induced by the initiation--promotion protocol in NMRI mouse skin. , 1995, Carcinogenesis.

[127]  M. Simionescu,et al.  The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. , 1994, The Journal of biological chemistry.

[128]  E. Vollmer,et al.  MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner , 1993 .

[129]  K. O. Elliston,et al.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.

[130]  M. Karas,et al.  Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. , 1991, The Journal of biological chemistry.

[131]  N. Hogg,et al.  Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. , 1991, The Journal of biological chemistry.

[132]  Y. Takasaki,et al.  Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases. , 1990, Journal of biochemistry.

[133]  E. Lingaas,et al.  Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin , 1990, The Lancet.

[134]  C. Hayward,et al.  Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. , 1988, Journal of cell science.

[135]  C. Sorg,et al.  Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. , 1988, Clinical and experimental immunology.

[136]  R. G. Clerc,et al.  Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis , 1987, Nature.

[137]  I. Dale,et al.  Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. , 1983, European journal of biochemistry.

[138]  S. Belman,et al.  The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones. , 1972, Cancer research.